US Stock MarketDetailed Quotes

Acrivon Therapeutics (ACRV)

Watchlist
  • 1.910
  • +0.020+1.06%
Close Apr 24 16:00 ET
  • 1.940
  • +0.030+1.57%
Post 20:01 ET
74.00MMarket Cap-0.95P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Acrivon Therapeutics (ACRV) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
3.05%-63.67M
12.23%-15.24M
29.09%-12.28M
-19.47%-16.61M
-14.35%-19.54M
-54.00%-65.67M
-40.38%-17.36M
-76.66%-17.32M
-52.58%-13.9M
-50.42%-17.08M
Net income from continuing operations
3.29%-77.91M
16.85%-18.99M
18.75%-18.23M
-11.75%-21.01M
-19.37%-19.68M
-33.40%-80.56M
-18.59%-22.83M
-55.13%-22.44M
-35.10%-18.8M
-29.24%-16.49M
Depreciation and amortization
34.79%1.36M
19.14%361K
39.04%349K
46.93%335K
38.84%311K
87.69%1.01M
103.36%303K
88.72%251K
76.74%228K
79.20%224K
Other non cash items
10.19%1.03M
9.05%265K
9.75%259K
11.35%255K
10.71%248K
19.79%932K
25.26%243K
19.19%236K
17.44%229K
17.28%224K
Change In working capital
-199.51%-2.43M
-104.68%-99K
-32.26%1.47M
-97.36%52K
-0.87%-3.85M
-70.04%2.44M
-49.22%2.12M
17.42%2.16M
-23.01%1.97M
-786.51%-3.81M
-Change in prepaid assets
-19.83%190K
-62.23%-756K
-176.90%-223K
157.51%703K
232.86%466K
-88.77%237K
-377.38%-466K
491.89%290K
-80.82%273K
-76.39%140K
-Change in payables and accrued expense
-140.97%-1.82M
-72.87%800K
-40.82%1.96M
-120.81%-400K
-11.38%-4.18M
-34.61%4.44M
-29.95%2.95M
58.10%3.32M
45.39%1.92M
-342.57%-3.75M
-Change in other current assets
111.62%137K
--137K
----
----
----
---1.18M
--0
----
----
----
-Change in other current liabilities
11.28%-936K
23.91%-280K
-3.79%-274K
-12.05%-251K
34.17%-131K
-39.92%-1.06M
-72.77%-368K
-45.86%-264K
-21.08%-224K
-13.71%-199K
Cash from discontinued investing activities
Operating cash flow
3.05%-63.67M
12.23%-15.24M
29.09%-12.28M
-19.47%-16.61M
-14.35%-19.54M
-54.00%-65.67M
-40.38%-17.36M
-76.66%-17.32M
-52.58%-13.9M
-50.42%-17.08M
Investing cash flow
Cash flow from continuing investing activities
227.68%66.1M
49.35%21.52M
-63.08%5.91M
122.09%19.45M
228.44%19.21M
-202.08%-51.77M
-29.82%14.41M
956.13%16.01M
-555.29%-88.04M
-37.28%5.85M
Net PPE purchase and sale
39.70%-1.67M
73.52%-219K
9.10%-899K
-259.85%-493K
92.88%-58K
-114.91%-2.77M
28.15%-827K
---989K
-22.32%-137K
-3,160.00%-815K
Net investment purchase and sale
238.30%67.77M
42.68%21.74M
-59.94%6.81M
122.69%19.94M
189.15%19.27M
-194.23%-49M
-29.73%15.24M
1,021.37%17M
-551.96%-87.91M
-28.73%6.67M
Cash from discontinued investing activities
Investing cash flow
227.68%66.1M
49.35%21.52M
-63.08%5.91M
122.09%19.45M
228.44%19.21M
-202.08%-51.77M
-29.82%14.41M
956.13%16.01M
-555.29%-88.04M
-37.28%5.85M
Financing cash flow
Cash flow from continuing financing activities
-100.62%-749K
70.32%-192K
92.22%-117K
-100.08%-97K
-99.42%-343K
7,888.10%121.03M
67.83%-647K
-2,028.21%-1.5M
32,446.17%123.35M
-172K
Net common stock issuance
--0
--0
--0
----
----
--70M
--0
--0
----
----
Proceeds from stock option exercised by employees
-100.00%1K
--0
--0
--0
-98.73%1K
7,653.94%60.09M
--0
--0
15,734.83%60.01M
--79K
Net other financing activities
91.72%-750K
70.32%-192K
92.22%-117K
98.54%-97K
-37.05%-344K
-289.14%-9.06M
---647K
---1.5M
---6.66M
---251K
Cash from discontinued financing activities
Financing cash flow
-100.62%-749K
70.32%-192K
92.22%-117K
-100.08%-97K
-99.42%-343K
7,888.10%121.03M
67.83%-647K
-2,028.21%-1.5M
32,446.17%123.35M
---172K
Net cash flow
Beginning cash position
9.85%40.02M
-18.35%35.61M
-9.33%42.1M
57.26%39.35M
9.85%40.02M
21.81%36.43M
44.07%43.61M
20.65%46.43M
-10.23%25.02M
21.81%36.43M
Current changes in cash
-53.00%1.69M
269.54%6.1M
-130.43%-6.49M
-87.18%2.74M
94.18%-664K
-45.00%3.59M
-158.37%-3.6M
65.71%-2.82M
101.82%21.4M
-461.82%-11.41M
End cash Position
4.21%41.7M
4.21%41.7M
-18.35%35.61M
-9.33%42.1M
57.26%39.35M
9.85%40.02M
9.85%40.02M
44.07%43.61M
20.65%46.43M
-10.23%25.02M
Free cash flow
4.53%-65.33M
15.02%-15.46M
28.01%-13.18M
-21.82%-17.1M
-9.47%-19.59M
-55.79%-68.44M
-34.55%-18.19M
-86.74%-18.31M
-52.21%-14.04M
-57.25%-17.9M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 3.05%-63.67M12.23%-15.24M29.09%-12.28M-19.47%-16.61M-14.35%-19.54M-54.00%-65.67M-40.38%-17.36M-76.66%-17.32M-52.58%-13.9M-50.42%-17.08M
Net income from continuing operations 3.29%-77.91M16.85%-18.99M18.75%-18.23M-11.75%-21.01M-19.37%-19.68M-33.40%-80.56M-18.59%-22.83M-55.13%-22.44M-35.10%-18.8M-29.24%-16.49M
Depreciation and amortization 34.79%1.36M19.14%361K39.04%349K46.93%335K38.84%311K87.69%1.01M103.36%303K88.72%251K76.74%228K79.20%224K
Other non cash items 10.19%1.03M9.05%265K9.75%259K11.35%255K10.71%248K19.79%932K25.26%243K19.19%236K17.44%229K17.28%224K
Change In working capital -199.51%-2.43M-104.68%-99K-32.26%1.47M-97.36%52K-0.87%-3.85M-70.04%2.44M-49.22%2.12M17.42%2.16M-23.01%1.97M-786.51%-3.81M
-Change in prepaid assets -19.83%190K-62.23%-756K-176.90%-223K157.51%703K232.86%466K-88.77%237K-377.38%-466K491.89%290K-80.82%273K-76.39%140K
-Change in payables and accrued expense -140.97%-1.82M-72.87%800K-40.82%1.96M-120.81%-400K-11.38%-4.18M-34.61%4.44M-29.95%2.95M58.10%3.32M45.39%1.92M-342.57%-3.75M
-Change in other current assets 111.62%137K--137K---------------1.18M--0------------
-Change in other current liabilities 11.28%-936K23.91%-280K-3.79%-274K-12.05%-251K34.17%-131K-39.92%-1.06M-72.77%-368K-45.86%-264K-21.08%-224K-13.71%-199K
Cash from discontinued investing activities
Operating cash flow 3.05%-63.67M12.23%-15.24M29.09%-12.28M-19.47%-16.61M-14.35%-19.54M-54.00%-65.67M-40.38%-17.36M-76.66%-17.32M-52.58%-13.9M-50.42%-17.08M
Investing cash flow
Cash flow from continuing investing activities 227.68%66.1M49.35%21.52M-63.08%5.91M122.09%19.45M228.44%19.21M-202.08%-51.77M-29.82%14.41M956.13%16.01M-555.29%-88.04M-37.28%5.85M
Net PPE purchase and sale 39.70%-1.67M73.52%-219K9.10%-899K-259.85%-493K92.88%-58K-114.91%-2.77M28.15%-827K---989K-22.32%-137K-3,160.00%-815K
Net investment purchase and sale 238.30%67.77M42.68%21.74M-59.94%6.81M122.69%19.94M189.15%19.27M-194.23%-49M-29.73%15.24M1,021.37%17M-551.96%-87.91M-28.73%6.67M
Cash from discontinued investing activities
Investing cash flow 227.68%66.1M49.35%21.52M-63.08%5.91M122.09%19.45M228.44%19.21M-202.08%-51.77M-29.82%14.41M956.13%16.01M-555.29%-88.04M-37.28%5.85M
Financing cash flow
Cash flow from continuing financing activities -100.62%-749K70.32%-192K92.22%-117K-100.08%-97K-99.42%-343K7,888.10%121.03M67.83%-647K-2,028.21%-1.5M32,446.17%123.35M-172K
Net common stock issuance --0--0--0----------70M--0--0--------
Proceeds from stock option exercised by employees -100.00%1K--0--0--0-98.73%1K7,653.94%60.09M--0--015,734.83%60.01M--79K
Net other financing activities 91.72%-750K70.32%-192K92.22%-117K98.54%-97K-37.05%-344K-289.14%-9.06M---647K---1.5M---6.66M---251K
Cash from discontinued financing activities
Financing cash flow -100.62%-749K70.32%-192K92.22%-117K-100.08%-97K-99.42%-343K7,888.10%121.03M67.83%-647K-2,028.21%-1.5M32,446.17%123.35M---172K
Net cash flow
Beginning cash position 9.85%40.02M-18.35%35.61M-9.33%42.1M57.26%39.35M9.85%40.02M21.81%36.43M44.07%43.61M20.65%46.43M-10.23%25.02M21.81%36.43M
Current changes in cash -53.00%1.69M269.54%6.1M-130.43%-6.49M-87.18%2.74M94.18%-664K-45.00%3.59M-158.37%-3.6M65.71%-2.82M101.82%21.4M-461.82%-11.41M
End cash Position 4.21%41.7M4.21%41.7M-18.35%35.61M-9.33%42.1M57.26%39.35M9.85%40.02M9.85%40.02M44.07%43.61M20.65%46.43M-10.23%25.02M
Free cash flow 4.53%-65.33M15.02%-15.46M28.01%-13.18M-21.82%-17.1M-9.47%-19.59M-55.79%-68.44M-34.55%-18.19M-86.74%-18.31M-52.21%-14.04M-57.25%-17.9M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +16.17%
Sample Name
Sample Code
 +12.91%
Sample Name
Sample Code
 +12.09%
4
VanEck Oil Services ETF
OIH
+5.81%
5
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.90%
Sample Name
Sample Code
 +11.93%
Sample Name
Sample Code
 +8.63%
4
United Microelectronics
UMC
+5.32%
5
Chagee Holdings
CHA
+3.37%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -